Rep. J. French Hill Sells CVS Health Co. (NYSE:CVS) Stock

Representative J. French Hill (R-Arkansas) recently sold shares of CVS Health Co. (NYSE:CVS). In a filing disclosed on February 04th, the Representative disclosed that they had sold between $15,001 and $50,000 in CVS Health stock on January 31st. The trade occurred in the Representative’s “HILL FAMILY FUND” account.

CVS Health Price Performance

NYSE:CVS opened at $55.62 on Thursday. The firm’s fifty day moving average price is $51.11 and its two-hundred day moving average price is $56.06. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The company has a market cap of $69.99 billion, a P/E ratio of 14.12, a P/E/G ratio of 0.62 and a beta of 0.61. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.21 earnings per share. Equities analysts expect that CVS Health Co. will post 5.14 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.78%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 67.51%.

Analyst Ratings Changes

Several brokerages have recently commented on CVS. StockNews.com cut shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. Mizuho dropped their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a report on Thursday, October 24th. Truist Financial reduced their target price on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Barclays cut their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research report on Tuesday, December 3rd. One research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $68.12.

Institutional Investors Weigh In On CVS Health

A number of hedge funds have recently made changes to their positions in CVS. AMF Tjanstepension AB increased its holdings in shares of CVS Health by 124.1% in the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after buying an additional 34,198 shares during the period. Czech National Bank increased its stake in CVS Health by 7.2% in the 3rd quarter. Czech National Bank now owns 256,430 shares of the pharmacy operator’s stock worth $16,124,000 after purchasing an additional 17,206 shares during the period. GAMMA Investing LLC lifted its position in CVS Health by 14.6% in the third quarter. GAMMA Investing LLC now owns 10,347 shares of the pharmacy operator’s stock valued at $651,000 after purchasing an additional 1,315 shares during the last quarter. Value Partners Investments Inc. grew its holdings in shares of CVS Health by 0.4% in the third quarter. Value Partners Investments Inc. now owns 1,195,276 shares of the pharmacy operator’s stock worth $75,159,000 after purchasing an additional 4,354 shares during the last quarter. Finally, City Center Advisors LLC raised its holdings in CVS Health by 64.3% during the 3rd quarter. City Center Advisors LLC now owns 11,546 shares of the pharmacy operator’s stock valued at $726,000 after buying an additional 4,519 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

About Representative Hill

French Hill (Republican Party) is a member of the U.S. House, representing Arkansas’ 2nd Congressional District. He assumed office on January 3, 2015. His current term ends on January 3, 2027.

Hill (Republican Party) is running for re-election to the U.S. House to represent Arkansas’ 2nd Congressional District. He declared candidacy for the 2026 election.

Hill is the founder and chairman of Delta Trust & Bank. He has served as senior policy advisor to President George H.W. Bush, Deputy Assistant Secretary of the U.S. Treasury and senior advisor to Governor Mike Huckabee.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.